UiPath founder Daniel Dines has written a book that dares readers to prove it wrong by 2028

The Next Web highlights Daniel Dines’ book, The Work That Remains, proposing that AI agents handle preparatory work while humans retain control of consequential decisions. The piece frames the thesis around a prior prediction and explicitly notes the types of evidence that would falsify it. Overall, this is conceptual/organizational commentary with limited immediate market or earnings implications.

Analysis

This is more a battle over control points than a pure AI adoption story. The economic value migrates toward vendors that own identity, workflow orchestration, and auditability; the weakest link is any software layer whose only moat is deterministic task execution. That puts platform software with embedded governance in a better position than standalone automation names that can be bypassed by native agent frameworks.

Near term, the market may overread the rhetoric and bid the obvious “automation” proxy, but enterprises usually separate experimentation from production for months. The first P&L evidence will be in pipeline conversion and attach rates, not headline agent demos; if those do not improve, the narrative fades quickly. Over 6-18 months, the real test is whether agents can operate inside ERP/CRM with provable controls; if not, adoption stays tactical and revenue uplift remains incremental rather than structural.

The contrarian risk is that this framework actually validates a larger services and governance spend, while commoditizing the middle layer. In that world, consultants, security, and workflow platform vendors capture the budget, while pure-play RPA multiples compress because investors realize the user interface layer is not the scarce asset. Watch for compliance incidents or a slowdown in enterprise software net retention as the clearest falsifiers of the bullish AI-automation thesis.

Key Decisions for Investors

• Initiate a 1-3 month pair trade: long MSFT or NOW / short PATH on any post-news strength. Thesis: platform vendors capture governance and orchestration spend while legacy automation multiple expands ahead of fundamentals.
• Do not chase PATH long here; wait for the next two quarters of billings, RPO, and NRR. If management cannot show agent-driven net new ARR, fade rallies above recent trading ranges.
• Use XLK or IGV as a lower-beta long if you want exposure to enterprise AI workflow adoption without single-name execution risk; pair against PATH if you want to isolate the disruption thesis.
• Set an alert for any enterprise security/compliance incident involving agentic workflows. That would delay production rollouts by 1-2 quarters and invalidate the near-term acceleration thesis.
• If PATH reports an actual inflection in billings tied to agent orchestration or governance modules, cover the short quickly; that would be the first hard signal that the market is underestimating its repositioning.